| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $1.69B | +6.1% | +10.7% |
| Cost of Revenue | $927.2M | -0.9% | +4.4% |
| R&D Expense | $109.6M | +0.3% | +4.9% |
| SG&A Expense | $250.6M | +7.8% | -1.1% |
| Operating Income | $23.1M | +848.7% | +140.7% |
| Pre-tax Income | $44.1M | -0.6% | +436.6% |
| Income Tax | -$2.0M |
| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $1.31B | +42.9% | +69.5% |
| Short-term Investments | $686.6M | -21.8% | -40.6% |
| Current Assets | $3.00B | +8.6% | +4.5% |
| Total Assets | $5.94B | +10.7% | +12.9% |
| Current Liabilities | $4.14B | +5.6% | +7.5% |
| Long-term Debt |
| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | $922.2M | — | — |
| Investing Cash Flow | $316.5M | — | — |
| Financing Cash Flow | -$511.4M | — | — |
| -148.1% |
| -187.2% |
| Net Income | $46.1M | +14.3% | +470.8% |
| EPS (Basic) | $0.11 | +10.0% | +466.7% |
| EPS (Diluted) | $0.11 | +10.0% | +466.7% |
| $1.06B |
| +85.4% |
| +5.8% |
| Total Liabilities | $5.37B | +15.8% | +16.6% |
| Stockholders' Equity | $573.0M | -21.8% | -12.6% |